RxMargin analyses your dispensing income line by line — reimbursement, rebates, price concessions and procurement — and shows you exactly where money is leaking and how to recover it.
Reimbursement, Drug Tariff changes, Category M, monthly price concessions, supplier rebates and procurement decisions all move independently. A line that made money last quarter can quietly turn into a loss. Most practices simply don't have the time, or the tooling, to track it at the level where the money actually moves.
Illustrative of the approach. Findings and figures are specific to each practice's own data.
Net cost versus reimbursement for every line, so loss-making and over-tariff items surface immediately instead of hiding in the average.
Tracks supplier rebate schemes and monthly price concessions, flagging where you're below the rates you could be earning.
Identifies genuine shortage losses, concession-dependent risk and cheaper same-month sourcing you missed — with the value at stake.
Partner-ready reports, an interactive dashboard, and submission-ready workbooks — delivered through your own secure portal.
Dispensing data, wholesaler invoices and remittances, sent securely. We provide a simple checklist.
Our audited workflow reconciles every line and audits the figures before anything is reported.
Dashboards and reports appear in your private portal — only your practice and our team can see them.
A prioritised list of recoverable margin, refreshed each period so you can track the impact.
Email us about an initial review and we'll explain what we'd need and what you'd get back.